Kühn Jens-Peter, Meffert Peter, Heske Christian, Kromrey Marie-Luise, Schmidt Carsten O, Mensel Birger, Völzke Henry, Lerch Markus M, Hernando Diego, Mayerle Julia, Reeder Scott B
From the Institute of Diagnostic Radiology and Neuroradiology (J.P.K., C.H., M.L.K., C.O.S., B.M.), Institute for Community Medicine (P.M., H.V.), and Department of Medicine A, University Medicine (M.M.L., J.M.), Ernst Moritz Arndt University Greifswald, Berthold-Beitz-Platz, 17495 Greifswald, Germany; Department of Radiology, University of Wisconsin, Madison, Wis (D.H., S.B.R.); and Department of Medical Physics, Biomedical Engineering, Medicine and Emergency Medicine, University of Wisconsin, Madison, Wis (S.B.R.).
Radiology. 2017 Sep;284(3):706-716. doi: 10.1148/radiol.2017161228. Epub 2017 May 5.
Purpose To quantify liver fat and liver iron content by measurement of confounder-corrected proton density fat fraction (PDFF) and R2* and to identify clinical associations for fatty liver disease and liver iron overload and their prevalence in a large-scale population-based study. Materials and Methods From 2008 to 2013, 2561 white participants (1336 women; median age, 52 years; 25th and 75th quartiles, 42 and 62 years) were prospectively recruited to the Study of Health in Pomerania (SHIP). Complex chemical shift-encoded magnetic resonance (MR) examination of the liver was performed, from which PDFF and R2* were assessed. On the basis of previous histopathologic calibration, participants were stratified according to their liver fat and iron content as follows: none (PDFF, ≤5.1%; R2*, ≤41.0 sec), mild (PDFF, >5.1%; R2*, >41 sec), moderate (PDFF, >14.1%; R2*, >62.5 sec), high (PDFF: >28.0%; R2*: >70.1 sec). Prevalence of fatty liver diseases and iron overload was calculated (weighted by probability of participation). Clinical associations were identified by using boosting for generalized linear models. Results Median PDFF was 3.9% (range, 0.6%-41.5%). Prevalence of fatty liver diseases was 42.2% (1082 of 2561 participants); mild, 28.5% (730 participants); moderate, 12.0% (307 participants); high content, 1.8% (45 participants). Median R2* was 34.4 sec (range, 14.0-311.8 sec). Iron overload was observed in 17.4% (447 of 2561 participants; mild, 14.7% [376 participants]; moderate, 0.8% [20 participants]; high content, 2.0% [50 participants]). Liver fat content correlated with waist-to-height ratio, alanine transaminase, uric acid, serum triglycerides, and blood pressure. Liver iron content correlated with mean serum corpuscular hemoglobin, male sex, and age. Conclusion In a white German population, the prevalence of fatty liver diseases and liver iron overload is 42.2% (1082 of 2561) and 17.4% (447 of 2561). Whereas liver fat is associated with predictors related to the metabolic syndrome, liver iron content is mainly associated with mean serum corpuscular hemoglobin. RSNA, 2017 Online supplemental material is available for this article.
目的 通过测量经混杂因素校正的质子密度脂肪分数(PDFF)和R2来量化肝脏脂肪和肝脏铁含量,并在一项大规模的基于人群的研究中确定脂肪肝疾病和肝脏铁过载的临床关联及其患病率。材料与方法 2008年至2013年,2561名白人参与者(1336名女性;年龄中位数52岁;第25和第75四分位数分别为42岁和62岁)被前瞻性纳入波美拉尼亚健康研究(SHIP)。对肝脏进行了复杂化学位移编码磁共振(MR)检查,评估了PDFF和R2。根据先前的组织病理学校准,参与者按肝脏脂肪和铁含量分层如下:无(PDFF≤5.1%;R2*≤41.0秒)、轻度(PDFF>5.1%;R2*>41秒)、中度(PDFF>14.1%;R2*>62.5秒)、重度(PDFF>28.0%;R2*>70.1秒)。计算脂肪肝疾病和铁过载的患病率(按参与概率加权)。通过广义线性模型的增强法确定临床关联。结果 PDFF中位数为3.9%(范围0.6%-41.5%)。脂肪肝疾病的患病率为42.2%(2561名参与者中的1082名);轻度,28.5%(730名参与者);中度,12.0%(307名参与者);含量高,1.8%(45名参与者)。R2*中位数为34.4秒(范围14.0-311.8秒)。17.4%(2561名参与者中的447名)观察到铁过载;轻度,14.7%(376名参与者);中度,0.8%(20名参与者);含量高,2.0%(50名参与者)。肝脏脂肪含量与腰高比、丙氨酸转氨酶、尿酸、血清甘油三酯和血压相关。肝脏铁含量与平均红细胞血红蛋白、男性性别和年龄相关。结论 在德国白人人群中,脂肪肝疾病和肝脏铁过载的患病率分别为42.2%(2561名中的1082名)和17.4%(2561名中的447名)。肝脏脂肪与代谢综合征相关预测因素有关,而肝脏铁含量主要与平均红细胞血红蛋白相关。RSNA,2017 本文提供在线补充材料。